The von-Hippel Lindau tumor suppressor protein (pVHL) is conserved throughout evolution, as its homologues are found in organisms ranging from mammals to the Drosophila melanogaster and Anopheles gambiae insects and the Caenorhabditis elegans nematode. Although the physiological role of pVHL is not fully understood, it has been shown to interact with a large number of unrelated proteins and was suggested to play a role in protein degradation as an E3 ubiquitin ligase component in the ubiquitin pathway. To gain insight into the molecular basis of pVHL activity, we analyzed its folding and stability in solution under physiologically relevant conditions. Dynamic light-scattering and gel filtration chromatography of the purified pVHL clearly indicated that the Stokes radius of the protein is larger than what would be expected from its crystal structure. However, under these conditions, the protein shows a clear secondary structure as determined by far-UV circular dichroism. Yet, the near-UV CD experiments show an absence of a tertiary structure. Upon the addition of urea, even at very low concentrations, the protein unfolds in a non-reversible manner, leading to the formation of amorphous aggregates. Furthermore, a large increase in fluorescence (>50-fold) is observed upon the addition of pVHL into a solution containing 8-anilino-1-naphthalene sulfonic acid. We therefore conclude that, under native conditions, the non-bound pVHL has a molten globule configuration with marginal stability. Although molten globular structures can be induced in many proteins under extreme conditions, this is one of the few reported cases of such a structure under the physiological conditions of pH, ionic strength, and temperature. The significance of the pVHL structural properties is being discussed in the context of its physiological activities.
The von-Hippel Lindau tumor suppressor protein (pVHL) is conserved throughout evolution, as its homologues are found in organisms ranging from mammals to the Drosophila melanogaster and Anopheles gambiae insects and the Caenorhabditis elegans nematode. Although the physiological role of pVHL is not fully understood, it has been shown to interact with a large number of unrelated proteins and was suggested to play a role in protein degradation as an E3 ubiquitin ligase component in the ubiquitin pathway. To gain insight into the molecular basis of pVHL activity, we analyzed its folding and stability in solution under physiologically relevant conditions. Dynamic light-scattering and gel filtration chromatography of the purified pVHL clearly indicated that the Stokes radius of the protein is larger than what would be expected from its crystal structure. However, under these conditions, the protein shows a clear secondary structure as determined by far-UV circular dichroism. Yet, the near-UV CD experiments show an absence of a tertiary structure. Upon the addition of urea, even at very low concentrations, the protein unfolds in a non-reversible manner, leading to the formation of amorphous aggregates. Furthermore, a large increase in fluorescence (>50-fold) is observed upon the addition of pVHL into a solution containing 8-anilino-1-naphthalene sulfonic acid. We therefore conclude that, under native conditions, the non-bound pVHL has a molten globule configuration with marginal stability. Although molten globular structures can be induced in many proteins under extreme conditions, this is one of the few reported cases of such a structure under the physiological conditions of pH, ionic strength, and temperature. The significance of the pVHL structural properties is being discussed in the context of its physiological activities.
Mutations in the von Hippel-Lindau (VHL)
1 tumor suppressor protein (pVHL) are associated with the hereditary VHL syndrome. This disease is characterized by a predisposition to develop retinal angiomas, cerebellar and spinal hemangioblastomas, renal cell carcinomas, pheochromocytomas, pancreatic adenomas and islet cell tumors, epididymal cystadenomas, and endolymphatic sac tumors of the inner ear (1) . The inactivation of the VHL protein occurs at the early stages of the pathogenesis of kidney lesions and clear cell renal carcinoma and is considered to be the most frequent genetic event at the onset of human kidney cancer (2, 3) .
The product of the VHL gene is a 213-amino acid protein (4) . A second form of pVHL is generated by translation initiation at an internal methionine, located at residue 54, with a molecular mass of 19 kDa (4). The structure of the 19-kDa pVHL protein was determined by x-ray crystallography in a ternary complex with Elongin C and Elongin B (5). Another recently elucidated crystal structure of this complex, which interacts with a 20-residue destruction sequence of HIF-1␣ and contains a functional hydroxyproline, was recently elucidated (6) . The crystal structures show that the pVHL molecule consists of two domains, ␣ and ␤. Both domains are connected by two short polypeptide linkers and a polar interface that is stabilized by a hydrogen bond network. The ␤-domain of pVHL consists of a seven-stranded ␤-sandwich (residues 63-154) and an ␣-helix (residues 193-204) that packs against one of the ␤-sheets through hydrophobic interactions. The ␣-domain of pVHL (residues 155-192) consists of three ␣-helices (5). Still, no unbound crystal structures or structures of pVHL in solution are available.
Like other tumor suppressors, the pVHL protein has a regulatory function in many cellular pathways, and it is suggested that many different factors interact with the pVHL protein in direct or indirect forms (7) . The pVHL protein is suggested to have a role in the regulation of transcription of many downstream elements. Biochemical studies have revealed that pVHL forms a ternary complex (VCB) with Elongin C and Elongin B proteins via a similar binding site, as exists in Elongin A (8 -10) . This interaction could indicate that one of the pVHL tumor suppressor roles is inhibition of elongation due to competition with Elongin A in the complex formation (5, 8 -11) . Furthermore, it has been demonstrated that pVHL binds directly to the transcription factor sp1 in vitro, hence suggesting that pVHL could be a regulator of the transcription of vascular endothelial growth factor (VEGF) mRNA (12) . Subsequently, it was demonstrated that pVHL binds directly to protein kinase C (PKC), a regulator that binds alternatively to sp1 and phosphorylates it (13) . Accordingly, it has been proposed that pVHL indirectly regulates a variety of downstream mRNA targets encoding platelet-derived growth factor B (PDGF-B), glucose transporter 1 (GLUT-1), transforming growth factor ␣ (TGF-␣), and carbonic anhydrase 9 and12 (CA9 and CA12) (1, 14, 15) .
Additional studies have shown that pVHL has a specific role in targeting different proteins for degradation. This role is carried out via the ubiquitylation pathway, where pVHL is associated with an active E3 ubiquitin ligase multiprotein complex (5, 6, 16 -22) . In the context of the VCB ternary complex, the pVHL protein binds to Cul2 and Rbx1 via Elongin B and forms the VCB-CR complex, an analogue of the SCF (Skp1-Cul1-F-box) complex (5, 8, 11, 23) . Protein kinase C and the heteronuclear ribonucleoprotein A2 (hnRNP A2) have been shown to be substrates of the VCB-CR ubiquitin ligase complex (15, 24) . Moreover, it has been shown that pVHL plays a central role in the cellular response to changes in oxygen availability, as hypoxia-inducible transcription factors HIF-1␣ and HIF-2␣ have been shown to be targets of the VCB-CR ubiquitin ligase complex (6, 16 -22) . A recent study revealed a novel ubiquitylation target, the VHL-interacting deubiquitinating enzyme 1 (VDU1), which is recruited into the VCB complex and binds directly to pVHL. VDU1 is suggested to act as a protease responsible for deubiquitylation of downstream ubiquitinated targets of the VCB-CR complex (25) . Other studies have suggested that pVHL is involved in the extracellular matrix metabolism where it directly interacts with fibronectin, and its inactivation leads to impaired extracellular fibronectin organization in VHL(Ϫ) cells (26) . Another recent study has proposed that pVHL regulates integrins and is essential for the formation of ␤1 fibrillar adhesions, which are involved in cytoskeletal rearrangement and required for the organization of fibronectin (27) . Additionally, the pVHL protein has been associated with regulation of the stability of microtubules and their protection from depolymerization through direct interaction (28) . Another stabilization role was observed with the short-lived protein Jade-1 (gene for apoptosis and differentiation in epithelia). This protein, which is highly expressed in the kidney, is stabilized by its strong interaction with the pVHL protein (29) . Finally, the unassembled form of pVHL is associated with two different types of molecular chaperones, Hsp70 and TriC/CCT (30, 31) .
The biological significance of pVHL is evident by its evolutionary conservation. Homologues of the mammalian pVHL protein are found in low invertebrates such as Drosophila melanogaster, Anopheles gambiae, and Caenorhabditis elegans. As more complete eukaryotic genomes are sequenced, we will expect to find additional pVHL homologues along the evolutionary tree. The understanding of pVHL structure-function relationship in the context of its unbound solution structure is therefore highly important. Such studies are significant in the wider context of structure and stability of other tumor suppressor proteins as well. The wild-type p53 tumor suppressor protein was found to be relatively unstable; its isolated core domain had moderate thermodynamic stability with relatively small changes leading to loss of function (32) . Likewise, the wild-type p16 (INK4a) tumor suppressor protein was found to have low stability and to be highly vulnerable to mutations, which altered its secondary structure and global fold (33, 34) . These findings may imply that intrinsic instability could be a functional trait in tumor suppressors and may be the means by which these key role proteins modulate their activity. Here, we examine the secondary structure, hydrodynamic characteristics, core packing, and thermodynamic stability of the pVHL tumor suppressor protein in solution under physiologically relevant conditions by using biophysical techniques. The results of our studies, as presented here, allow better understanding of the role of the pVHL protein in various cellular processes and may shed light on the general paradigm of tumor suppressor proteins.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification-The BL21(DE3) strain of Escherichia coli was co-transformed by electroporation (Bio-Rad MicroPulser) with two plasmids that were kindly provided to us by Dr. Nikola Pavletich (Memorial Sloan-Kettering Cancer Center, New York). The first plasmid, pGEX-4T-3, includes the human VHL gene (residues 54 to 213) fused to glutathione S-transferase (GST) and the full-length human Elongin B gene as a dicistronic massage. The second plasmid, pBB75, includes the human Elongin C gene (residues 17 to 112). Transformed cells were grown at 37°C, 200 rpm, in 2XYT medium under dual antibiotic selection (100 g/ml ampicillin and 30 g/ml kanamycin). Cells were induced overnight at 25°C with two doses of 1 mM isopropyl-1-thio-␤-D-galactopyranoside and supplementary ampicillin (100 g/ ml); one dose was applied at A 600 ϭ 0.8 -1, and a second dose was applied after 6 h of induction. Cells were harvested by centrifugation, and the pellets were frozen at Ϫ70°C before purification. Cell pellets were resuspended in suspension buffer (50 mM Tris-HCl, pH 8, 200 mM NaCl, 10 mM dithiothreitol, 5 mM phenylmethylsulfonyl fluoride, and mixture protease inhibitor), and suspended cells were lysed by a French press cell disruptor at 14,000 p.s.i. The lysate was treated with DNase (10 units/ml) and centrifuged for 30 min, at 4°C. Supernatant was filtered through a 0.45 m filter (Corning) and subjected to GSTrap FF 1-ml column (Amersham Biosciences) using theÄKTA prime automated liquid chromatography system (Amersham Biosciences). The GST-pVHL fusion protein was treated on column with thrombin protease (Amersham Biosciences) overnight to cleave the GST moiety, and purified pVHL was eluted with 50 mM Tris-HCl, pH 8, and 200 mM NaCl. Purification was assessed by Coomassie staining of SDS/PAGE. Protein concentration was determined from absorbance at 280 nm using ⑀ 280 nm ϭ 17,900 cm
CD Spectra Measurements-CD spectra at far-(200 -250 nm) and near-UV (250 -320 nm) were recorded with an AVIV 202 spectropolarimeter (Aviv Instruments, Lakewood NJ) equipped with a temperature-controlled cell using a cell of pathlength 0.5 cm; bandwidth was 1 nm, and averaging time was 30 s for each measurement. Protein concentration was 3 m (far-UV) and 7 M (near-UV) in a buffer containing 50 mM Tris-HCl (pH 8) and 200 mM NaCl.
Chemical Denaturation-Urea denaturation studies were carried out using CD. A solution of 3 M protein in buffer (50 mM Tris-HCl, pH 8, and 200 mM NaCl) was mixed stepwise with appropriate amounts of the same solution containing 6 M urea to achieve the appropriate concentration of protein and denaturant for the chemical denaturation. Changes in ellipticity were scanned from 222 to 218 nm for each step of urea addition; bandwidth was 1 nm, averaging time was 30 s, and cell pathlength was 0.5 cm. Measurements were conducted at 37 and 25°C.
Size Exclusion Chromatography-Gel filtration experiments were performed using a Sephacryl S100 16/60 column (Amersham Pharmacia Biotech) with a separation range of 1-100 kDa connected to an ⌬KTA prime automated liquid chromatography system (Amersham Biosciences). The running buffer used was 50 mM Tris-HCl pH 8, and 200 mM NaCl. The column was calibrated using gel filtration low molecular weight standards (Amersham Biosciences). A 1-ml sample at a final protein concentration of 8 M was chromatographically analyzed using a flow rate of 0.5 ml/min. Absorbance was monitored at 280 nm, and elution volumes were determined from UV chromatogram. The partition coefficient, K av , was calculated from the elution volume of the sample, V e , and total bed volume, V t , using the expression:
. Calibration curves and equations were established.
Dynamic Light-scattering Measurements-Hydrodynamic radius (R H ) measurements were made at 25°C with a DynaPro MSTC800 instrument (Protein Solutions Inc., Charlottesville, VA). A sample (50 l) containing 0.3 mg/ml protein in buffer (50 mM Tris-HCl, pH 8, and 200 mM NaCl) was centrifuged and filtered to avoid dust particles. The sample was placed directly in a quartz cuvette, and the light-scattering intensity was collected at an angle of 90°using a 10-s acquisition time at 74% laser power. Particle diffusion coefficient was calculated from auto-correlated light intensity data and converted to R H with the Stokes-Einstein equation. A histogram of the percentage of the scattering mass versus R H was calculated using Dynamics data analysis software (Protein Solutions).
8-Anilino-1-naphthalene Sulfonic Acid (ANSA) Fluorescence Studies-Fluorescence emission spectra of two solutions were generated with excitation wavelength of 350 nm. The first solution contained 3 M ANSA in buffer (50 mM Tris-HCl, pH 8, and 200 mM NaCl). The second solution was similar and contained protein at a final concentration of 3 M. Samples were equilibrated at room temperature. The fluorescence emission spectra were recorded (Luminescence Spectrometer LS50B, PerkinElmer Life Sciences). The cuvette length was 1 cm. Measurements were conducted at room temperature. Baseline corrections were made with buffer lacking protein and ANSA, but otherwise identical.
Analytical Ultracentrifugation-Sedimentation equilibrium experiments were performed overnight at 20°C on a Beckman Optima XL-A analytical ultracentrifuge (Beckman Instruments) equipped with 12-mm Epon double sector cells in an An-60 Ti rotor. Protein was analyzed in PBS buffer (pH 7.4). Sedimentation equilibrium scans were carried out at 21,000 rpm. Absorbance of sedimenting material was assayed at 232 nm. Molecular masses were evaluated from ln A versus r 2 plots employing the SEGAL computer program based on the concept of numerical fitting of the sedimentation equilibrium pattern where A is the absorbance and r is the distance from the rotor center. A partial specific volume of 0.73 cm 3 /g was used for all calculations. Fluorescence Labeling and Spectroscopy-Purified VHL protein was reacted with two equivalents of N-hydroxysuccinimide fluorescein ester (Pierce) in PBS (pH 8) for 24 h at room temperature in the dark as described (35) . Unreacted dye was separated from labeled protein by gel filtration chromatography on a MicroSpin G-50 Sephadex column (Amersham Biosciences). Fluorescence emission and anisotropy were monitored in PBS using a PerkinElmer Life Sciences LS50B fluorescence spectrophotometer.
RESULTS
Although the crystal structure of pVHL was determined in the context of the ternary complex with Elongin proteins using x-ray crystallography (5, 6), the structure of the protein in solution and its unbound structure have not yet been studied. To gain insight on the structure of the protein under such conditions, we studied the secondary and tertiary structure, the hydrodynamic properties, the thermal and chemical stability, and the core packing of pVHL under near-physiological solvent conditions using biophysical techniques.
Determination of Secondary and Tertiary Structure by Circular Dichroism-Initial information regarding the secondary and tertiary structure of the purified, unbound pVHL in solution was obtained by CD. The far-UV CD spectra of pVHL at 25°C, shown in Fig. 1A , reveals spectral signals consistent with a protein comprising an intact secondary structure, rendering both ␣-helices and ␤-sheets. The ␣-helical and ␤-sheet content estimated by deconvolution of the CD spectra (k2d; www.embl-heidelberg.de/ϳandrade/k2d) shows 29% ␣-helix content and 34% ␤-sheet content. This is consistent with the secondary structure of the bound pVHL protein as determined previously by x-ray crystallography (5). The near-UV CD spectra of pVHL at 25°C shown in Fig. 1B reveals no significant signals originating from aromatic side chains, thus suggesting a dramatic loss of tertiary structure of the soluble and unbound protein in comparison with the complex-related crystal structure.
Chemical Denaturation-The thermodynamic instability of tumor suppressor proteins appears to be a common structural denominator (32) (33) (34) . We therefore studied the thermodynamic stability of purified pVHL using urea melt at two different temperatures (37 and 25°C). The degree of denaturation was assessed by monitoring ellipticity changes at 222 and 218 nm as a function of urea concentrations. As can be observed in Fig.  2 , the unfolding of pVHL occurs at fairly low urea concentrations. Unfolding as reflected by a significant reduction in ellip- ticity was observed at urea concentrations as low as 0.25 M at both temperatures. Furthermore, the unfolding event was partially irreversible, and the formation of amorphous aggregates could be visualized by the naked eye. Therefore, no exact thermodynamic parameters could be calculated. However, the linear nature of the initial slope of the curve and the aggregative behavior implies that unbound pVHL stability is marginal, as was observed previously with other tumor suppressor proteins (33) .
Size Exclusion Chromatography-The marginal stability of pVHL, as observed in the chemical denaturation experiments, raised the possibility that pVHL might be partially unfolded in its unbound state. Size exclusion chromatography was therefore used to estimate the hydrodynamic dimensions of the protein and as a probe for elucidating the compactness of the protein's tertiary structure, because the elution volume of partially or fully unfolded proteins is significantly smaller than that of well folded proteins due to the large increase in the Stokes radius. We performed size exclusion chromatography in 50 mM Tris-HCl, pH 8, containing 200 mM NaCl. The pVHL protein was eluted at a volume of 58.5 ml on a calibrated column (as described under "Experimental Procedures"), which is very close to the ovalbumin standard (M w ϭ 43,000 Da) elution volume. Fig. 3 presents column calibration curves and the hydrodynamic parameters corresponding to the elution of the pVHL protein. Fig. 3A shows the K av versus M w plot; the calculated K av for pVHL was 0.191, corresponding to a molecular mass of 47,130 Da (calculated with curve's equation), which is larger than the theoretical molecular mass value of pVHL (19,000 Da). Fig. 3B shows ͌-logK av versus Stokes radius (R S ); according to this relation, the calculated R S for pVHL is 30.8 Å.
Dynamic Light Scattering-To examine the degree of compactness of the pVHL protein and obtain an estimation of the apparent Stokes radius of pVHL, we measured its diffusion coefficient by dynamic light scattering. Essentially 99.7% of the scattering mass was attributed to a single component (Fig. 4) . The measured hydrodynamic radius was 3 nm, and the estimated molecular mass was 43 kDa. These values, taken together with the size exclusion chromatography results, are significantly larger for the solution form of the protein than the values obtained from the folded pVHL crystal structure. This could indicate a somewhat flexible and non-compact conformation for the unbound protein.
ANSA Fluorescence Studies-The near-UV CD studies revealed a significant loss of tertiary structure, and the size exclusion chromatography results, in addition to results the dynamic light-scattering experiments, were clearly consistent with a partially unfolded structure. However, because a significant secondary structure of pVHL was observed in the far-UV CD studies, we suspected that pVHL structure in these conditions is molten globular. Therefore, we studied the fluorescence of pVHL in the presence of the hydrophobic probe ANSA. The increase in florescence of ANSA is one of the most efficient criteria for distinguishing between folded, molten globule, and unfolded states. The fluorescence of the hydrophobic ANSA probe is much stronger in the presence of molten globular state of proteins than with a rigid, well folded, or fully unfolded state (36) . Fig. 5 shows that, upon binding to pVHL, ANSA fluorescence intensity increases by 50-fold, whereas the emission spectrum indicates a blue shift toward 400 nm. This could suggest that the hydrophobic core exists, but in a rather loosely packed conformation, and is therefore consistent with a molten globule tertiary structure.
Analytical Ultracentrifugation-The hydrodynamic radius of the pVHL, as determined by both dynamic light-scattering and size exclusion chromatography, was almost twice what would be expected for a globular protein of pVHL molecular mass. Because the radius is significantly large as compared with common molten globular proteins, we further wanted to determine whether the protein exists as a dimer in its basic form. To determine the oligomeric state of the fundamental pVHL unit, sedimentation equilibrium analytical ultracentrifugation was used. Analysis of molecular distribution at equilibrium (Fig. 6) clearly demonstrated the existence of a monomeric pVHL species. The sedimentation equilibrium data fit well to a single species with a calculated apparent molecular mass of 18,200 Da, implying that pVHL is monomeric in solution. This agrees very well with the M r established by SDS gel electrophoresis and the M r of 8,500 Da predicted for pVHL from the DNA sequence. There was some degree of aggregation, as observed at the lower part of the tube. This may reflect a moderate degree of nonspecific aggregation as may be expected for a partially unfolded protein after long incubation at high concentration. However, it is certainly not consistent with a dimeric nature of the discrete forms that were observed by dynamic light-scattering and size exclusion chromatography.
Fluorescence Anisotropy-To further establish whether the VHL protein undergoes the oligomerization process at lower concentrations than those applied at the analytical ultracentrifugation experiment, fluorescence labeling was used. The VHL protein was labeled with fluorescein. The fluorescence emission and anisotropy were monitored for the labeled protein in a 1:1 molar ratio mixture with unlabeled VHL protein. No significant changes in either the fluorescence emission or anisotropy were observed upon the addition of the unlabeled protein, even though it was followed for 24 h. This is also consistent with a monomeric state of the protein with no fluorescence quenching due to intermolecular interactions.
DISCUSSION
It was already established that proteins can exist in nonnative conformations such as fully unfolded, partially unfolded, or molten globular forms (32) (33) (34) (35) (36) (37) (38) (39) (40) (41) (42) . However, the physiological significance of such conformations is not fully understood. an apparent secondary structure ( Fig. 2A) with no tertiary structure (Fig. 2B) . The typical non-compact structure was additionally determined by size exclusion chromatography (Fig. 3) and dynamic light-scattering experiments (Fig. 4) ; the calculated R S for pVHL is 30.8 Å, which is larger than the calculated 17.469-Å gyration radii (MOLEMAN 2) of the protein in the complex-associated crystal structure of pVHL (Protein Data Bak code 1VCB; www.rcsb.org/pdb/index.html). Although the determined dimensions of the protein molecule are rather larger than that of the canonical molten globule, analytical ultracentrifugation (Fig. 6 ) and fluorescence experiments confirm the notion that the VHL protein exists in a monomeric conformation rather than in a dimeric state. Furthermore, such a significant increase in ANSA fluorescence (Fig. 5) clearly indicates a molten globule structure rather than the existence of a monomeric or dimeric well folded protein or, alternatively, an unfolded one. Because the crystal structure of pVHL is a somewhat elongated trapezoid, the apparent dimensions, as biophysically determined, should be significantly larger than that of a globular protein of the same molecular mass.
The thermodynamic stability of the secondary structure as observed by CD is also marginal; at very low concentrations of urea the protein undergoes denaturation (Fig. 2) , which results in some extent of aggregation. Because of the irreversible nature of the unfolding reaction, the exact thermodynamic parameters cannot be determined. However, one could estimate that the change in free energy upon folding would be significantly lower than the values obtained from reversible, urea-dependent unfolding reactions of other known proteins, which exhibit a two-state, denaturant-induced unfolding. Although the molten globular structures of cellular non-secreted proteins are usually observed only under extreme environment conditions (e.g. pH, temperature, etc.), this is one of the few known cases in which a cellular protein appears to be natively molten globule. The question that arises from this research concerns the physiological significance of this configuration and its implications on the functional mechanism. The molten globule form was suggested to be involved in a number of physiological processes in the living cell, mostly in translocation across membranes, binding to liposomes and phospholipids, and the secretion of proteins (43) (44) (45) (46) (47) (48) . Well known examples of physiologically relevant, natively molten globule proteins are the secreted apolipoproteins A-1 and E-4, which mediate the binding and transport of lipids throughout the body (45, 46) , and the milk proteins ␣-lactoalbumin and -casein (47) , where the noncompact configuration of the protein is assumed to be important for the optimization of its availability as a source of amino acids for the suckling baby. The manganese stabilizing protein (MSP) of photosystem II (PS II) attains a molten globule structure in solution, as well, and it appears that the molten globule structure in this case satisfies several regulatory functions such as optimal binding to the PSII complex or trafficking between the different compartments of the plant cell (48) . The case of pVHL is completely different.
pVHL plays an essential regulatory role in many cellular processes, where it interacts with various unrelated cellular proteins. Some of the known interacting proteins in the pVHL regulatory network are Elongin C, Elongin B, Cul2, Rbx1, protein kinase C, protein kinase C, the heteronuclear ribonucleoprotein A2, HIF-1␣, sp1, the VHL-interacting deubiquitinating enzyme 1, fibronectin, integrins, microtubule, and Jade-1. However, the exact role of pVHL in these interactions is not yet fully established. Several experiments have shown that pVHL is functional in ubiquitin-related protein degradation processes, and it was suggested to act as an E3 ligase (6, (15) (16) (17) (18) (19) (20) (21) (22) 24) . Alternatively, pVHL was recently suggested to be associated with the role of protein stabilization (29) . Furthermore, the association of the pVHL protein with a number of target proteins seems to execute transcriptional regulation of many mRNA transcripts in both a direct and indirect manner (1, 5, 8 -15, 24) . We speculate that the unique folding properties of the pVHL protein are a key feature of this protein's diverse activities, as its flexibility enables recognition of a variety of protein targets and may allow its multiple functions. The nonrigid structure observed in the monomeric form of pVHL can facilitate an induced fit interaction with such different proteins while retaining some degree of secondary structure, which may be necessary, though, for initial and specific recognition.
Tumor suppressors function at the molecular level in many regulatory pathways, such as inhibitors of cell growth, inductors of apoptosis or differentiation, DNA damage repair, and modulators of the microenvironment in which tumor cells grow, via the regulation of extracellular matrix proteins, adhesion proteins, or secreted growth factors (49) . These proteins interact with many active complexes and bind and recognize many target proteins; therefore, when altered by mutations, these proteins are associated with the manifestation of numerous types of cancers. Thermodynamic studies of other tumor suppressors, such as p53 or p16 (32-34, 37, 38, 50) , are consistent with our findings regarding the pVHL tumor suppressor. This interesting correlation may imply that a rather unstable structure is a key feature of tumor suppressor proteins. Dunker and co-workers recently predicted, using a neural network approach, that there is a significant degree of intrinsic disorder in cancer-associated proteins and cell-signaling proteins (51). These observations are very consistent with the observations we present here.
